| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | 0.13 | 0.001 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.18 | 0.001 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | YM201636 | GDSC1000 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.16 | 0.002 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | -0.17 | 0.002 |
| mRNA | AZD1480 | CTRPv2 | pan-cancer | AAC | 0.17 | 0.002 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.002 |